GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
2.4k
c/glp1science·posted 2 years ago by u/yusuf_ramos

three years of incretin threads, summarised so you do not have to read them

Discussion Receipts ×2 Clean Column ×3

three years of incretin threads, summarised so you do not have to read them — a position I have arrived at slowly and would like tested.

Why mechanism talk keeps misleading people, including me.

A mechanism tells you a direction. It does not tell you a magnitude, a timescale, or whether the pathway is operative at the exposures involved. "Receptor X is expressed in tissue Y" is a fact; "therefore effect Z in a person" is a hypothesis with several missing steps.

The corrective is boring and it works: ask whether the evidence is preclinical or human, ask what exposure was used, and read the limitations section before the abstract. Most of the confidently wrong posts on this board — several of them mine — skipped all three.

GLP-1 receptor agonism acts both peripherally — insulin secretion in a glucose-dependent way, slowed gastric emptying — and centrally, on appetite regulation. The central component is the better explanation for sustained intake reduction.

The incretin effect is the observation that oral glucose provokes a larger insulin response than intravenous glucose at matched glycaemia, and the difference is mediated by gut hormones. That is the foundation the whole class sits on.

If somebody has the same thing measured a different way, post it next to mine and we will see whether they agree.

3,048 up / 657 down82% upvoted29 commentsid 1xfmdk21 Feb 2024

29 comments

9 in this archive, depth 3

best — the order this archive was captured in

u/emil_agyeman195 points·2 years ago

Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally.

replysharereportpermalink
[deleted]80 points·2 years ago

[deleted]

replysharereportpermalink
u/laila_almeida52 points·2 years ago

a mechanism you can state is not a mechanism you have demonstrated

replysharereportpermalink
u/katrin_marchetti38 points·2 years ago

glucagon agonism sounds paradoxical until you read the energy expenditure work

replysharereportpermalink
u/the_poster_in_question_2026121 points·2 years ago·edited

Disagree. That is a preclinical finding in a rodent model and you are stating it as human pharmacology.

replysharereportpermalink
u/camila_lindqvist104 points·2 years ago

Spent an evening on the receptor distribution literature and the side-effect map suddenly stopped looking random.

replysharereportpermalink
u/camila_kowalski-5 points·2 years ago

receptor distribution is why the side effects are where they are

replysharereportpermalink
u/lina_ndiaye-6 points·2 years ago

Read the primary paper after arguing about the summary for a fortnight. The discussion section said almost the opposite of what the thread had concluded.

replysharereportpermalink
u/amara_dziedzic56 points·2 years ago

Careful — you have a plausible mechanism and no evidence that it is the operative one in the case you are describing.

replysharereportpermalink
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.